These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
395 related articles for article (PubMed ID: 18550814)
1. Phospholipase D1 is an effector of Rheb in the mTOR pathway. Sun Y; Fang Y; Yoon MS; Zhang C; Roccio M; Zwartkruis FJ; Armstrong M; Brown HA; Chen J Proc Natl Acad Sci U S A; 2008 Jun; 105(24):8286-91. PubMed ID: 18550814 [TBL] [Abstract][Full Text] [Related]
2. Tuberous sclerosis complex gene products, Tuberin and Hamartin, control mTOR signaling by acting as a GTPase-activating protein complex toward Rheb. Tee AR; Manning BD; Roux PP; Cantley LC; Blenis J Curr Biol; 2003 Aug; 13(15):1259-68. PubMed ID: 12906785 [TBL] [Abstract][Full Text] [Related]
3. Biochemical and functional characterizations of small GTPase Rheb and TSC2 GAP activity. Li Y; Inoki K; Guan KL Mol Cell Biol; 2004 Sep; 24(18):7965-75. PubMed ID: 15340059 [TBL] [Abstract][Full Text] [Related]
4. Non-canonical functions of the tuberous sclerosis complex-Rheb signalling axis. Neuman NA; Henske EP EMBO Mol Med; 2011 Apr; 3(4):189-200. PubMed ID: 21412983 [TBL] [Abstract][Full Text] [Related]
6. The tuberous sclerosis protein TSC2 is not required for the regulation of the mammalian target of rapamycin by amino acids and certain cellular stresses. Smith EM; Finn SG; Tee AR; Browne GJ; Proud CG J Biol Chem; 2005 May; 280(19):18717-27. PubMed ID: 15772076 [TBL] [Abstract][Full Text] [Related]
7. Farnesyltransferase inhibitors reverse altered growth and distribution of actin filaments in Tsc-deficient cells via inhibition of both rapamycin-sensitive and -insensitive pathways. Gau CL; Kato-Stankiewicz J; Jiang C; Miyamoto S; Guo L; Tamanoi F Mol Cancer Ther; 2005 Jun; 4(6):918-26. PubMed ID: 15956249 [TBL] [Abstract][Full Text] [Related]
8. Neurofibromatosis-1 regulates mTOR-mediated astrocyte growth and glioma formation in a TSC/Rheb-independent manner. Banerjee S; Crouse NR; Emnett RJ; Gianino SM; Gutmann DH Proc Natl Acad Sci U S A; 2011 Sep; 108(38):15996-6001. PubMed ID: 21896734 [TBL] [Abstract][Full Text] [Related]
9. Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling. Inoki K; Li Y; Xu T; Guan KL Genes Dev; 2003 Aug; 17(15):1829-34. PubMed ID: 12869586 [TBL] [Abstract][Full Text] [Related]
10. Insulin activation of Rheb, a mediator of mTOR/S6K/4E-BP signaling, is inhibited by TSC1 and 2. Garami A; Zwartkruis FJ; Nobukuni T; Joaquin M; Roccio M; Stocker H; Kozma SC; Hafen E; Bos JL; Thomas G Mol Cell; 2003 Jun; 11(6):1457-66. PubMed ID: 12820960 [TBL] [Abstract][Full Text] [Related]
11. Rhebbing up mTOR: new insights on TSC1 and TSC2, and the pathogenesis of tuberous sclerosis. Kwiatkowski DJ Cancer Biol Ther; 2003; 2(5):471-6. PubMed ID: 14614311 [TBL] [Abstract][Full Text] [Related]
12. Redox regulates mammalian target of rapamycin complex 1 (mTORC1) activity by modulating the TSC1/TSC2-Rheb GTPase pathway. Yoshida S; Hong S; Suzuki T; Nada S; Mannan AM; Wang J; Okada M; Guan KL; Inoki K J Biol Chem; 2011 Sep; 286(37):32651-60. PubMed ID: 21784859 [TBL] [Abstract][Full Text] [Related]
13. Control of TSC2-Rheb signaling axis by arginine regulates mTORC1 activity. Carroll B; Maetzel D; Maddocks OD; Otten G; Ratcliff M; Smith GR; Dunlop EA; Passos JF; Davies OR; Jaenisch R; Tee AR; Sarkar S; Korolchuk VI Elife; 2016 Jan; 5():. PubMed ID: 26742086 [TBL] [Abstract][Full Text] [Related]
14. Regulation of B-Raf kinase activity by tuberin and Rheb is mammalian target of rapamycin (mTOR)-independent. Karbowniczek M; Cash T; Cheung M; Robertson GP; Astrinidis A; Henske EP J Biol Chem; 2004 Jul; 279(29):29930-7. PubMed ID: 15150271 [TBL] [Abstract][Full Text] [Related]
15. TBC1D7 is a third subunit of the TSC1-TSC2 complex upstream of mTORC1. Dibble CC; Elis W; Menon S; Qin W; Klekota J; Asara JM; Finan PM; Kwiatkowski DJ; Murphy LO; Manning BD Mol Cell; 2012 Aug; 47(4):535-46. PubMed ID: 22795129 [TBL] [Abstract][Full Text] [Related]
16. Analysis of mTOR signaling by the small G-proteins, Rheb and RhebL1. Tee AR; Blenis J; Proud CG FEBS Lett; 2005 Aug; 579(21):4763-8. PubMed ID: 16098514 [TBL] [Abstract][Full Text] [Related]
17. Activation of Rheb, but not of mTORC1, impairs spine synapse morphogenesis in tuberous sclerosis complex. Yasuda S; Sugiura H; Katsurabayashi S; Shimada T; Tanaka H; Takasaki K; Iwasaki K; Kobayashi T; Hino O; Yamagata K Sci Rep; 2014 Jun; 4():5155. PubMed ID: 24889507 [TBL] [Abstract][Full Text] [Related]
18. Rheb binds tuberous sclerosis complex 2 (TSC2) and promotes S6 kinase activation in a rapamycin- and farnesylation-dependent manner. Castro AF; Rebhun JF; Clark GJ; Quilliam LA J Biol Chem; 2003 Aug; 278(35):32493-6. PubMed ID: 12842888 [TBL] [Abstract][Full Text] [Related]
19. TSC1/TSC2 and Rheb have different effects on TORC1 and TORC2 activity. Yang Q; Inoki K; Kim E; Guan KL Proc Natl Acad Sci U S A; 2006 May; 103(18):6811-6. PubMed ID: 16627617 [TBL] [Abstract][Full Text] [Related]
20. Ral and Rheb GTPase activating proteins integrate mTOR and GTPase signaling in aging, autophagy, and tumor cell invasion. Martin TD; Chen XW; Kaplan RE; Saltiel AR; Walker CL; Reiner DJ; Der CJ Mol Cell; 2014 Jan; 53(2):209-20. PubMed ID: 24389102 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]